{"session_id": 64, "bill_id": 23321, "bill_type": "Senate Concurrent Resolution", "bill_number": 603, "bill_title": "to raise awareness about tardive dyskinesia.", "sponsors": [{"legislator_profile_id": 4006, "is_prime": true}], "keywords": ["Senate Concurrent Resolution"], "audio": [], "bill_versions": [{"bill_id": 23321, "bill_version_id": 232400, "bill_version": "Introduced", "bill_version_date": "2022-02-03T12:00:47.887-06:00", "bill_text": "A CONCURRENT RESOLUTION, to raise awareness about tardive dyskinesia. WHEREAS, many people with serious, chronic mental illness, such as schizophrenia, bipolar disorder, severe depression, and gastrointestinal disorders, including gastroparesis, nausea, and vomiting, require treatment with medications that work as dopamine receptor blocking agents (DRBAs), including antipsychotics; and WHEREAS, while ongoing treatment with DRBAs can be helpful and even lifesaving for many people, it can also lead to tardive dyskinesia; and WHEREAS, tardive dyskinesia is a movement disorder that is characterized by random, involuntary, and uncontrolled movements of different muscles in the face, trunk, and extremities. Tardive dyskinesia can develop months, years, or decades after a person starts to take DRBAs and after discontinued use of DRBAs. Once developed, tardive dyskinesia is often permanent; and WHEREAS, according to the National Alliance for Mental Illness, over 600,000 Americans suffer from tardive dyskinesia, and one in every four patients receiving long-term treatment with an antipsychotic medication will experience tardive dyskinesia; and WHEREAS, years of difficult and challenging research have resulted in recent scientific breakthroughs, with two new treatments for tardive dyskinesia approved by the United States Food and Drug Administration; and WHEREAS, tardive dyskinesia is often unrecognized, and patients suffering from the illness are commonly misdiagnosed. Regular screening for tardive dyskinesia in patients taking DRBAs is recommended by the American Psychiatric Association; and WHEREAS, the Legislature can raise awareness of tardive dyskinesia in the public and medical community: NOW, THEREFORE, BE IT RESOLVED, by the Senate of the Ninety-Seventh Legislature of the State of South Dakota, the House of Representatives concurring therein, that the week of May 1, 2022, is to be known as \"Tardive Dyskinesia Awareness Week\"; and BE IT FURTHER RESOLVED, that all individuals are encouraged to become better informed about and aware of tardive dyskinesia."}, {"bill_id": 23321, "bill_version_id": 233900, "bill_version": "Enrolled", "bill_version_date": "2022-02-18T08:26:14.537-06:00", "bill_text": "A CONCURRENT RESOLUTION, to raise awareness about tardive dyskinesia. WHEREAS, many people with serious, chronic mental illness, such as schizophrenia, bipolar disorder, severe depression, and gastrointestinal disorders, including gastroparesis, nausea, and vomiting, require treatment with medications that work as dopamine receptor blocking agents (DRBAs), including antipsychotics; and WHEREAS, while ongoing treatment with DRBAs can be helpful and even lifesaving for many people, it can also lead to tardive dyskinesia; and WHEREAS, tardive dyskinesia is a movement disorder that is characterized by random, involuntary, and uncontrolled movements of different muscles in the face, trunk, and extremities. Tardive dyskinesia can develop months, years, or decades after a person starts to take DRBAs and after discontinued use of DRBAs. Once developed, tardive dyskinesia is often permanent; and WHEREAS, according to the National Alliance for Mental Illness, over 600,000 Americans suffer from tardive dyskinesia, and one in every four patients receiving long-term treatment with an antipsychotic medication will experience tardive dyskinesia; and WHEREAS, years of difficult and challenging research have resulted in recent scientific breakthroughs, with two new treatments for tardive dyskinesia approved by the United States Food and Drug Administration; and WHEREAS, tardive dyskinesia is often unrecognized, and patients suffering from the illness are commonly misdiagnosed. Regular screening for tardive dyskinesia in patients taking DRBAs is recommended by the American Psychiatric Association; and WHEREAS, the Legislature can raise awareness of tardive dyskinesia in the public and medical community: NOW, THEREFORE, BE IT RESOLVED, by the Senate of the Ninety-Seventh Legislature of the State of South Dakota, the House of Representatives concurring therein, that the week of May 1, 2022, is to be known as \"Tardive Dyskinesia Awareness Week\"; and BE IT FURTHER RESOLVED, that all individuals are encouraged to become better informed about and aware of tardive dyskinesia. Adopted by the Senate, February 7, 2022 Concurred in by the House of Representatives, February 16, 2022 _____________________ _____________________ Larry Rhoden Kay Johnson President of the Senate Secretary of the Senate _____________________ _____________________ Spencer Gosch Patricia Miller Speaker of the House Chief Clerk"}], "amendments": [], "fiscal_notes": [], "action_log": [{"bill_id": 23321, "action_date": "2022-02-04T13:00:00-06:00", "document_id": 232453, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/232453.pdf", "status_text": "First read in Senate and referral to committee waived pursuant to JR 6D-1", "journal_page": 182, "committee_id_action": 1034, "committee_id_assigned": null, "result": "N", "vote": {}}, {"bill_id": 23321, "action_date": "2022-02-07T14:00:00-06:00", "document_id": 232579, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/232579.pdf", "status_text": "Adopt Resolution", "journal_page": 191, "committee_id_action": 1034, "committee_id_assigned": null, "result": "P", "vote": {"vote_id": 72888, "president_vote": null, "Yea": [3918, 3920, 3921, 3922, 3925, 3926, 3932, 3935, 3936, 3939, 3940, 3943, 3949, 3952, 3956, 3958, 3961, 3962, 3966, 3974, 3975, 3979, 3990, 3991, 3993, 3994, 3996, 3999, 4000, 4002, 4003, 4006, 4010, 4012, 4016]}}, {"bill_id": 23321, "action_date": "2022-02-08T14:00:00-06:00", "document_id": 232771, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/232771.pdf", "status_text": "First Reading House", "journal_page": 235, "committee_id_action": 1008, "committee_id_assigned": null, "result": "N", "vote": {}}, {"bill_id": 23321, "action_date": "2022-02-15T14:00:00-06:00", "document_id": 233563, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/233563.pdf", "status_text": "Committee assignment waived", "journal_page": 323, "committee_id_action": 1008, "committee_id_assigned": null, "result": "N", "vote": {}}, {"bill_id": 23321, "action_date": "2022-02-16T14:00:00-06:00", "document_id": 233739, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/233739.pdf", "status_text": "Concurred in Resolution", "journal_page": 342, "committee_id_action": 1008, "committee_id_assigned": null, "result": "P", "vote": {"vote_id": 73978, "president_vote": null, "Yea": [3912, 3913, 3914, 3915, 3916, 3917, 3919, 3923, 3924, 3927, 3928, 3929, 3930, 3931, 3933, 3934, 3937, 3938, 3941, 3944, 3945, 3946, 3947, 3948, 3950, 3951, 3953, 3954, 3955, 3959, 3960, 3963, 3964, 3965, 3967, 3968, 3969, 3970, 3971, 3972, 3973, 3976, 3977, 3980, 3981, 3982, 3983, 3984, 3985, 3986, 3987, 3988, 3989, 3992, 3995, 3997, 3998, 4001, 4004, 4005, 4007, 4008, 4009, 4011, 4013, 4014, 4015, 3942], "Excused": [3957, 3978]}}]}